World News – GB – Sunday share tips: EKF Diagnostics, Spire Healthcare


Take a deep breath It is possible to do good and earn money – at the same time

This is the main reason why the Midas column of the Mail on Sunday decided this weekend to recommend buying shares of EKF Diagnostics.

The company, which focuses on neonatal care – saving babies – and ventilators in particular, has come a long way since its inception in 2003 and since listing on AIM in 2015, said Midas

Last July, the company took an important step by acquiring SLE, which should prove to be « transformative », according to the info

This was followed in October by the company’s first dividend, an interim payment of 02p per share

In addition, full year sales through January 2021 are expected to double to around £ 35million and profits are expected to reach £ 14m, the annual dividend should be 06p

EKF boss Neil Campbell wants to triple sales to at least £ 100million over the next five to seven years, which in turn should boost profits and dividends

« Campbell has a simple philosophy: good businesses should be growing, profitable and generating cash, » added Midas

« They should then reward shareholders who took the risk of investing in them Inspiration ticks all of those boxes It also helps some of the world’s most vulnerable children and has played a key role in the fight against Covid- 19 At 66p, stocks are a buy « 

Shares of Spire Healthcare have outperformed more recently, but remain well below the level they floated on AIM in 2014, Sabah Meddings wrote in the Sunday Times’ Inside the City column

Business appeared to be on the rise before the pandemic, causing the private hospital group’s income to drop 18% in half to £ 401 9m

This resulted in a pre-tax loss of £ 231.3m, compared to profits of £ 9.6m a year earlier

Indeed, if there had not been an agreement with the NHS under which Spire treats NHA patients and the health service covers its rents and salaries, the company could have gone bankrupt

This deal is expected to last at least until the end of 2020 “but what does the future hold when it ends?” Meddings asked aloud

More serious, the risk exists that people will postpone non-essential elective care due to the pandemic

« Speyer takeover prospect hinges on rebound in people buying private health insurance Rates have plunged this year

« Speyer shares have outperformed the market As NHS waiting lists remain long, the company will be eager to participate in tenders to move its operations to the private sector Yet Speyer is far from be in poor health and the future is uncertain Hold « 

LON: EKF, EKF Diagnostics Holdings, Share

News from around the world – GB – Sunday share tips: EKF Diagnostics, Spire Healthcare


Donnez votre avis et abonnez-vous pour plus d’infos

Vidéo du jour: